SCHEMBL7154707

SCHEMBL7154707

CO[C@H]([C@H](O)[C@@H](C)O)[C@H](C=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881496 1.00
SCHEMBL31387070 1.00
SCHEMBL11361209 1.00
SCHEMBL11389350 1.00
SCHEMBL11395005 1.00
SCHEMBL10401701 0.86
SCHEMBL2743440 0.86
SCHEMBL21586158 0.86
SCHEMBL8718277 0.86
SCHEMBL2168395 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083657-A1 LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE 한국생명공학연구원 2025-04-24 WO claimed
US-12594258-B2 Inhibitors of MHC-I Nef downmodulation for treating HIV THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2026-04-07 US disclosed
US-12569570-B2 Compositions and methods for targeted RNA delivery VERVE THERAPEUTICS, INC. (US) 2026-03-10 US disclosed
US-20260053912-A1 STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS UNITED STATES GOVERNMENT 2026-02-26 US disclosed
EP-4700124-A2 OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION Alnylam Pharmaceuticals, Inc. (US) 2026-02-25 EP disclosed
US-12478671-B2 Sterols as novel immunomodulatory agents and their use as vaccine adjuvants OHIO STATE INNOVATION FOUNDATION (US) 2025-11-25 US disclosed
US-20250338808-A1 COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS BOYCE THOMPSON INSTITUTE FOR PLANT RES INC (US) 2025-11-06 US disclosed
US-12382888-B2 Compositions and methods for modulating immunity in plants BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) 2025-08-12 US disclosed
US-20250236636-A1 COMPOSITIONS AND METHODS FOR CAPPING RNAS VERVE THERAPEUTICS, INC. 2025-07-24 US disclosed
US-20250236685-A1 DEGRADABLE POLYMERS THE TRUSTEES OF BOSTON COLLEGE 2025-07-24 US disclosed
WO-2022051677-A1 COMPOSITIONS AND METHODS FOR CAPPING RNAS VERVE THERAPEUTICS, INC. (US) 2022-03-10 WO disclosed
US-6562514-B1 Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries PINNACLE VRB LIMITED (AU) 2003-05-13 US disclosed
US-6468688-B2 CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE PINNACLE VRB LIMITED (AU) 2002-10-22 US disclosed
US-20010028977-A1 Charging, discharging efficiency; vanadium electrolyte JD HOLDING INC. (KY) 2001-10-11 US disclosed
US-6143443-A ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE PINNACLE ARB LIMITED (AU) 2000-11-07 US disclosed
EP-0829104-A1 HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1998-03-18 EP disclosed
EP-0729648-A4 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LTD (AU) 1997-01-02 EP disclosed
WO-1996035239-A1 HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1996-11-07 WO disclosed
EP-0729648-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1996-09-04 EP disclosed
WO-1995012219-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1995-05-04 WO disclosed